Search

Filters
Clear All
  • 16
  • 48
  • 626

Phase

  • 12
  • 15
  • 53
  • 8
  • 72
  • 5
  • 516
  • 611
  • 279
  • 676
  • 14

Found 690 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Stacey Tarvin, MD
21 years or below
All genders
Observational
This study investigates how childhood-onset neuropsychiatric systemic lupus erythematosus (NPSLE) affects cognitive functions over time. Systemic lupus erythematosus (SLE) is a disease where the immune system attacks the body, causing inflammation and damage. The study uses a tool called pedANAM to assess cognitive and behavioral functions in children with this …
H
Hristos Kaimakliotis, MD
18 years - 100 years
All genders
This study investigates the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) for patients with recurrent non-muscle invasive bladder cancer. Non-muscle invasive bladder cancer is a type of cancer that affects the bladder but does not invade the muscle layer. Gemcitabine is a chemotherapy drug that stops cancer …
R
Roman Natoli, MD
100 years or below
All genders
The purpose of this research study is to help determine the best treatment for preventing blood clots that are formed following trauma that could potentially lead to death. At the moment researchers do not know if using medications called low molecular weight heparin or aspirin is better in preventing life …
J
Jason Mackey
18 years or above
All genders
Observational
The overall goal of the DISCOVERY study is to better understand what factors contribute tohanges in cognitive (i.e., thinking and memory) abilities in patients who experienced ake. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities …
J
Jared Brosch, MD
18 years - 100 years
All genders
Observational
What is the purpose of this study?ALZ-NET is a national, volunteer provider-enrolled longitudinal cohort registry with an expandable platform, allowing for thecollection of real-world data from enrolled patients being evaluated for or treated with novel FDA- approved AD therapies. ALZ-NET will be a resource for evidence gathering, information sharing and …
C
Cynthia Brown, MD
6 years or above
All genders
Phase 4
Interventional
The purpose of this study is to look at pulmonary exacerbations in people with cysticbrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms inwith CF that needs medical intervention. Both …
D
Damien G. Patel, MD
40 years - 100 years
All genders
Phase 2
Interventional
What is the goal of this study?Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The purpose of this study is to determine the safety and efficacy of oral ifetroban compared to placebo in subjects with IPF. THIS STUDY IS ENROLLING BY INVITATION ONLY  
L
Leslie Hulvershorn, MD, MSc
10 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and tolerability of an investigational medication in young people with schizophrenia or bipolar disorder.  Schizophrenia is a mental disorder that affects how a person thinks, feels, and behaves. Bipolar disorder is a condition that causes extreme mood swings, including emotional highs (mania or hypomania) and lows (depression)
R
Raj Vuppalanchi, MD
18 years - 100 years
All genders
Interventional
What is the purpose of this study?This clinical trial (a medical research study) is an open-label extension of a previous research study, SARO.21.001, which evaluates the efficacy (improvement in liver enzymes and lipid profiles) and safety (side effects) of Saroglitazar Magnesium in participants with a medical condition known as Primary …
L
Lisa Landrum, MD, PhD, MS
18 years - 100 years
Female
Phase 2
What is the purpose of this study?This is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily. Translational Objectives: 1. To preliminarily assess IHC hormone receptor expression and correlation …
461 - 470 of 690